These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9727298)

  • 1. A sequential algorithm for the non-linear dual-sorption model of percutaneous drug absorption.
    Gumel AB; Kubota K; Twizell EH
    Math Biosci; 1998 Aug; 152(1):87-103. PubMed ID: 9727298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol.
    Kubota K; Koyama E; Twizell EH
    J Pharm Sci; 1993 Dec; 82(12):1205-8. PubMed ID: 8308696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonlinear numerical model of percutaneous drug absorption.
    Kubota K; Twizell EH
    Math Biosci; 1992 Mar; 108(2):157-78. PubMed ID: 1547360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lag time in the dual sorption model for percutaneous absorption with finite skin-receptor boundary clearance.
    Twizell EH; Kubota K
    Math Biosci; 1994 Sep; 123(1):1-23. PubMed ID: 7949743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global extrapolation of numerical methods for computing concentration profiles in percutaneous drug absorption.
    Twizell EH
    Comput Biol Med; 1989; 19(3):163-71. PubMed ID: 2721162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption: a single-layer model.
    Kubota K; Sznitowska M; Maibach HI
    J Pharm Sci; 1993 May; 82(5):450-6. PubMed ID: 8360820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrants.
    Chittenden JT; Brooks JD; Riviere JE
    J Pharm Sci; 2014 Mar; 103(3):1002-12. PubMed ID: 24481625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of viable skin layers in percutaneous permeation and its implication in mathematical models: theoretical consideration based on parameters for betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1994 Sep; 83(9):1300-6. PubMed ID: 7830247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vehicle properties on skin penetration of emedastine.
    Harada S; Takahashi Y; Nakagawa H; Yamashita F; Hashida M
    Biol Pharm Bull; 2000 Oct; 23(10):1224-8. PubMed ID: 11041256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diffusion-diffusion model for percutaneous drug absorption.
    Kubota K; Ishizaki T
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):409-39. PubMed ID: 3772740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A calculation of percutaneous drug absorption--II. Computation results.
    Kubota K; Ishizaki T
    Comput Biol Med; 1986; 16(1):21-37. PubMed ID: 3948493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous absorption, disposition, and exposure assessment of homosalate, a UV filtering agent, in rats.
    Kim TH; Shin BS; Kim KB; Shin SW; Seok SH; Kim MK; Kim EJ; Kim D; Kim MG; Park ES; Kim JY; Yoo SD
    J Toxicol Environ Health A; 2014; 77(4):202-13. PubMed ID: 24555679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
    Kubota K; Koyama E; Yasuda K
    J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2001 Apr; 90(4):504-20. PubMed ID: 11170040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
    Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
    Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.